Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus
Article in Current Medical Research and Opinion (September 2015)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
A randomized controlled trial of the efficacy and safety of saxagliptin as add‐on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
Article in Diabetes Obesity and Metabolism (December 2013)